Skip to main content

Genetics of Breast and Ovarian Cancer

A Continuum of Risk

  • Chapter
Cancer Genetics for the Clinician
  • 81 Accesses

Abstract

Genetics contributes to the risk of breast and ovarian cancer to a variable degree Rare families show dramatic clustering of breast and ovarian cancer, with cancers occurring at an early age.1 Most such families carry genetic alterations (or mutations) conferring an inherited predisposition to cancer. These families are often referred to as cancer-prone or high risk families; women from these families, if they inherit the cancer predisposition, may face a lifetime probability of cancer as high as 85–90%.1

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ford D, Easton DF: The genetics of breast and ovarian cancer. Br J Cancer 1995;72:805–812

    Article  PubMed  CAS  Google Scholar 

  2. Yang Q, Khoury MJ, Rodriguez C, Calle EE, Tatham LM, Flanders WD. Family history score as a predictor of breast mortality: prospective data from the cancer prevention study II, United States, 1982–1991. Am J Epidem 147:652–659, 1998

    Article  CAS  Google Scholar 

  3. Wellisch DK, Gritz ER, Schain W, et al: Psychological functioning of daughters of breast cancer patients. Part 1: Daughters and comparison subjects. Psychomatics 32:324–336, 1991

    Article  CAS  Google Scholar 

  4. Alexander NE, Ross J, Sumner W, Nease RF, Littenberg B. The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med 11:92–97, 1995

    Article  Google Scholar 

  5. Gallup Survey 1995, cited in Mortality vital statistics report, Medical Tribune, Jan 25, p 17, 1996

    Google Scholar 

  6. Parker SL, Tong T, Bolden S, Wingo PA: Cancer Statistics 1996. CA Cancer J Clin 46:5–27, 1996

    Article  PubMed  CAS  Google Scholar 

  7. Ferrar S. The anguished politics of breast cancer. NY Times Magazine 1993; Aug 15:24–27, 58-61

    Google Scholar 

  8. Shannon J: Portraints of breast cancer. Woman’s Day 1993; Oct 21:85, 88–90, 94,95

    Google Scholar 

  9. Colditz GA, Willett WC, Hunter DJ, Stampfer MJ, Manson JE, et al: Family history, age, and risk of breast cancer. JAMA 270:338–343, 1993

    Article  PubMed  CAS  Google Scholar 

  10. Slattery ML, Kerber RA: A comprehensive evaluation of family history and breast cancer risk: the Utah population database. JAMA 270:1563–1568, 1993

    Article  PubMed  CAS  Google Scholar 

  11. Pharoah PDP, Day NE, et al: Family history and the risk of breast cancer: A systematic review and meta-analysis. Int J Cancer 71:800–809,1997

    Article  PubMed  CAS  Google Scholar 

  12. Claus EB, Risch N, Thompson WB: Autosomal dominant inheritance of early onset breast cancer: Implications for risk prediction. Cancer 73:643–651, 1994

    Article  PubMed  CAS  Google Scholar 

  13. Kerber RA, Slattery ML: The impact of family history on ovarian cancer risk: the Utah population database. Arch Intern Med 155:905–912, 1995

    Article  PubMed  CAS  Google Scholar 

  14. Easton DF, Mathews FE, Ford D, Swerdlow AJ, Peto J: Cancer mortality in relatives of women with ovarian cancer: the OPCS study. Int J Cancer 65:284–294, 1996

    Article  PubMed  CAS  Google Scholar 

  15. Auranem A, Pukkala E, Makinen J, Samkila R, Grenman S, Salmi T: Cancer incidence in the first-degree relatives of ovarian cancer patients. Brit J Cancer 74:280–284, 1996

    Article  Google Scholar 

  16. Couch FJ, DeShano ML, Blackwood MA, et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409–1415, 1997

    Article  PubMed  CAS  Google Scholar 

  17. Shattuck-Eidens D, Oliphant A, McClure M, et al: BRCA1 sequence analysis in women at high risk for susceptibility mutations. JAMA 278:1242–1250, 1997

    Article  PubMed  CAS  Google Scholar 

  18. Wellisch DK, Gritz ER, Schain W, et al: Psychological functioning of daughters of breast cancer patients. Part 1: Daughters and comparison subjects. Psychomatics 32:324–336, 1991

    Article  CAS  Google Scholar 

  19. Ford D, Eastin DF, Stratton M, et al: Genetic heterogeity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676–689, 1998

    Article  PubMed  CAS  Google Scholar 

  20. Easton DF, Steele L, Fields P, et al: Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q 12–13. Amer J Hum Genei 61:120–128, 1997

    Article  CAS  Google Scholar 

  21. Rubin SC, Blackwood MA, Bandera C, et al: BRCA1, BRCA2 and hereditary non-polyposis col-orectal cancer gene mutations in an unselected ovarian cancer population: relationship to family hisotry and implications for genetic testing. Am J Ob Gynecol 178:670–677, 1998

    Article  CAS  Google Scholar 

  22. Watson P, Lynch HT: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71:677–685, 1993

    Article  PubMed  CAS  Google Scholar 

  23. Sidransky D, Tokino T, Helzlsouer K, et al: Inherited p53 gene mutations in breast cancer. Cancer Res 52:2984–2986, 1992

    PubMed  CAS  Google Scholar 

  24. Malkin D, Li FP, Strong LC, et al: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238, 1990

    Article  PubMed  CAS  Google Scholar 

  25. Liaw D, Marsh DJ, Li J, et al: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 16:64–67, 1997

    Article  PubMed  CAS  Google Scholar 

  26. Malone KE, Daling JR, Thompson JD, et al: BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA 279:922–929, 1998

    Article  PubMed  CAS  Google Scholar 

  27. Newman B, Mu H, Butler LM, et al: Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279:915–921, 1998

    Article  PubMed  CAS  Google Scholar 

  28. Kerber RA, Slattery ML: Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidem 146:244–248, 1997

    Article  CAS  Google Scholar 

  29. Parent M-E, Ghadrian PV, Lacroix A, Perret C: The reliability of recollections of family history: implications for the medical provider. J Cancer Ed 12:114–120, 1997

    CAS  Google Scholar 

  30. Burke W, Press N, Pinsky L: Breast carcinoma genetics from a primary care perspective. Cancer 80(Suppl):621–626, 1997

    Article  Google Scholar 

  31. Szabo C, King M-C: Population Genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013–1020, 1997

    PubMed  CAS  Google Scholar 

  32. Narod SA, Ford D, Devilee P, et al: An evaluation of genetic heterogeneity in 145 breast ovarian cancer families. Am J Hum Genet 56:254–264, 1995

    PubMed  CAS  Google Scholar 

  33. Struewing JP, Hartge P, Wacholder S, et al: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401–1408, 1997

    Article  PubMed  CAS  Google Scholar 

  34. Whittemore AS, Gong G, Itnyre J: Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet 60:496–504, 1997

    PubMed  CAS  Google Scholar 

  35. Thorlacius S, Olafsdottir G, Tryggvadottir L, et al: A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13:117–119, 1996

    Article  PubMed  CAS  Google Scholar 

  36. Thorlacius S, Sigurdsson S, Bjarnadottir H, et al: Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60:1079–1084, 1997

    PubMed  CAS  Google Scholar 

  37. Roa BB, Boyd AA, Volcik K, et al: Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185–187, 1996

    Article  PubMed  CAS  Google Scholar 

  38. Levy-Lahad E, Catane R, Eisenberg S, et al: Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet 60:1059–1067, 1997

    PubMed  CAS  Google Scholar 

  39. Richards CS, Ward PA, Roa BB, et al: Screening for 185delAG in the Ashkenazim. Am J Hum Genet 60:1085–1098, 1997

    PubMed  CAS  Google Scholar 

  40. Abeliovich D, Kaduri L, Lerer I, et al: The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60:505–514, 1997

    PubMed  CAS  Google Scholar 

  41. Li FP, Fraumeni JF, Jr, Mulvihill JJ, et al: A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358–5362, 1988

    PubMed  CAS  Google Scholar 

  42. Frebourg T, Barbier N, Yan YX, et al: Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 56:608–615, 1995

    PubMed  CAS  Google Scholar 

  43. Marra G, Boland CR: Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87:1114–1125, 1995

    Article  PubMed  CAS  Google Scholar 

  44. Aarnio M, Mecklin J-P, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ, Willett WC: Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer. 64:430–433, 1995

    Article  PubMed  CAS  Google Scholar 

  45. Rhyu MS: Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma. J Natl Cancer Inst 88:240–251, 1996

    Article  PubMed  CAS  Google Scholar 

  46. Watson P, Vasen HFA, Mecklin JD, et al: The risk of endometrial cancer in hereditary on polyposis colorectal cancer. Am J Med 96:516–520, 1994

    Article  PubMed  CAS  Google Scholar 

  47. D’Errico A, Taioli E, Chen X, Vineis P: Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers 1:149–173, 1996

    Article  Google Scholar 

  48. Burke W, Daly M, Garber J, et al: Recommendations for follow-up care of individuals with an inherited predisposition to cancer II. BRCA1 and BRCA2. JAMA 277:997–1003, 1997

    Article  PubMed  CAS  Google Scholar 

  49. Hartmann LC, Schaid DJ, Woods JE, et al: Efficacy of bilateral prophylactic mastectomy in women with a history of breast cancer. N Eng J Med 340(2):77–84, 1999

    Article  CAS  Google Scholar 

  50. Struewing JP, et al: Prophylactic oophorectomy in inherited breast/ovarian cancer families. J Natl Cancer Inst Monograph 17:33–35, 1995

    Google Scholar 

  51. Fisher B, Costantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-l Study. J Natl Cancer Inst 90(18):1371–1388, 1998

    Article  PubMed  CAS  Google Scholar 

  52. Burke W, Petersen G, Lynch P, Daly M, Garber JE, Botkin J, Kahn MJE, McTiernan A, Offit K, Thomson E, Varricchio C. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. 1. Hereditary nonpolyposis colon cancer JAMA 277:915–919, 1997

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Burke, W. (1999). Genetics of Breast and Ovarian Cancer. In: Shaw, G.L. (eds) Cancer Genetics for the Clinician. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4699-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4699-3_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7128-1

  • Online ISBN: 978-1-4615-4699-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics